Clinical trials of Covaxin for children begins at AIIMS Patna
The clinical trials of Bharat Biotech's Covaxin on children aged between two and 18 years have begun at All India Institute of Medical Sciences (AIIMS) Patna.
"Covaxin has been approved by the Drugs Controller General of India (DCGI) for Phase 2 and 3 clinical trials in the age group of two to 18 years. I have been told that trials will begin in the next 10-12 days," NITI Aayog's Member Health, Dr V.K. Paul said.
Earlier, in a meeting held by the Subject Expert Committee (COVID-19) on May 11, the proposal was further deliberated. While, on May 13, the DCGI permitted clinical trials of the vaccine for the 2-18 age group.
Besides, the clinical trials are likely to be conducted among over 500 participants at various hospitals across the country.
AIIMS Director Dr Randeep Guleria further said that the need of the hour is some quick data and risk-benefit analysis of the vaccine's use in children.
(Edited by Ridhika Joshi)
TNT-The Northeast Today is now on WhatsApp. CLICK HERE to receive more updates on your phone